Single-Center Validation of the Second Revised International Staging System (R2-Iss) in a Population of Transplant-Eligible (Te) Newly-Diagnosed Multiple Myeloma (Ndmm) Treated with Bortezomib-Based Regimens

AuthID
P-018-3VV
5
Author(s)
Martins, H
·
Lacerda, JF
·
Esteves, G
Tipo de Documento
Abstract
Year published
2024
Publicado
in BLOOD, ISSN: 0006-4971
Volume: 144, Páginas: 6977-6977 (1)
Indexing
Publication Identifiers
Wos: WOS:001412192700007
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.